Pediatrix Medical Group, Inc., along with its subsidiaries, specializes in providing comprehensive care services for newborns, expectant mothers, and pediatric patients with various medical needs across the United States and Puerto Rico. The earnings per share (EPS) is reported at -$1.24 indicating the company's profitability on a per-share basis. The gross profit stands at $2,012,919,000.00 highlighting the company's profitability from core operations. Additionally, the EBITDA is -$28,372,000.00 a key indicator of the company's operational profitability. The net income ratio is -$0.05 reflecting the company's profitability margin, while the income before tax ratio is -$0.05 demonstrating the pre-tax margin. With a network of approximately 2,700 physicians, the company offers neonatal care through specialized physician subspecialists and nurse practitioners, maternal-fetal services via affiliated clinicians, and pediatric cardiology care to all age groups, including adults with congenital heart defects. Furthermore, Pediatrix provides a range of pediatric subspecialty services through various experts, ensuring robust support within hospital settings, particularly in pediatric emergency rooms and labor and delivery areas. As for its stock performance, the stock is affordable at $14.13 suitable for budget-conscious investors. It has an average trading volume of 640,023.00 indicating moderate liquidity in the market. With a market capitalization of $1,243,670,904.00 the company is classified as a small-cap player. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Healthcare sector, driving innovation and growth. As the company continues to provide vital medical services, its financial metrics and stock performance reflect a promising position within its field, appealing to investors looking for opportunities in healthcare.